CNTX (CNTX) Stock Price & Analysis
CNTX (CNTX) fell 0.77% to USD 0.36 as of September 8, 2026 at 14:05 UTC, according to Nexqual real-time market data.
CNTX last closed at USD 0.36; the session ranged USD 0.35–0.37 on volume of 314,594 shares. Market capitalization is —, with a 52-week range of USD 0.35–3.62 (NCM). Source: Nexqual, September 8, 2026 at 14:05 UTC.
Key Statistics (as of September 8, 2026 at 14:05 UTC)
| Price | USD 0.36 |
|---|---|
| Change | ▼ 0.77% (down) |
| Previous Close | USD 0.36 |
| Open | USD 0.36 |
| Day Range | USD 0.35 – 0.37 |
| 52-Week Range | USD 0.35 – 3.62 |
| Volume | 314,594 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (CNTX)
Nexqual's technical model rates CNTX "SELL" based on 2 bullish and 5 bearish signals across 127 daily candles, as of September 8, 2026 at 14:05 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 28.87 (oversold) |
| vs SMA50 | Below (USD 0.54) |
| MACD | -0.07 (negative) |
From CNTX's Latest SEC 10-K Filing (filed 2026-03-23)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MRAI | Marpai, Inc. | USD 3.19 | ▲ 21.39% |
| KTTA | Pasithea Therapeutics Corp. | USD 0.59 | ▲ 2.24% |
| BFRI | Biofrontera Inc. | USD 1.58 | ▲ 4.64% |
| ENSC | Ensysce Biosciences, Inc. | USD 0.43 | ▼ 2.91% |
| PTPI | Petros Pharmaceuticals, Inc. | USD 0.01 | ▲ 20% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 14:05 UTC. This page is informational and not investment advice.